USFDA approves expanded use of Amgen’s psoriasis drug

The approval makes Otezla the first and only oral treatment option for that patient category

195
USFDA Approval
USFDA Approval

Last Updated on October 10, 2024 by The Health Master

The US Food and Drug Administration (USFDA) has approved the expanded use of Amgen Inc’s AMGN.O drug Otezla to treat adults with mild-to-moderate plaque psoriasis, the drugmaker said recently.

The approval makes Otezla the first and only oral treatment option for that patient category. It is already approved for three indications, including to treat patients with moderate-to-severe plaque psoriasis and psoriatic arthritis.

Amgen in 2019 bought Otezla for $13.4 billion in cash from Celgene Corp, which was earlier acquired by Bristol Myers Squibb. The drug brought in sales of $2.2 billion last year.

Plaque Psoriasis is a chronic inflammatory disease with patches of rough, red skin and silvery-white scales resulting from an uncontrolled immune response.

It is the most common form of skin disease, affecting about 6.7 million adults in the United States, according to the National Institute of Arthritis and Musculoskeletal and Skin Disease.

Otezla is also being tested for several other conditions, including pediatric plaque psoriasis and genital psoriasis.

USFDA gives nod to Cipla for Lanreotide injection

USFDA gives Orphan Drug Designation to Zydus for malaria treatment

USFDA relaxes restriction on Abortion Pill

USFDA approved Finasteride, Tadalafil for new treatment for Benign Prostatic Hyperplasia

USFDA issues Form 483 to Alembic Pharma Gujarat plant

IPC adds 15 new impurities Reference Substances and 11 IP Reference…

Drug alert: 22 out of 1102 samples declared as NSQ in…

Govt is able to collect data on only 237 Medical devices

IPC’s new 2nd edition of Guidance Manual for Monographs Development

USFDA completes audit at MSN Pharma with zero observations

Govt approves PLI scheme to promote domestic API production

Govt is working on policy to encourage research in Pharma sector

Pharmexcil to organize seminar on ‘Reinvigorating India’s Pharma Exports’

Haryana is the best state for setting up Pharma Industries: HM

Latest Notifications regarding Pharmaceuticals

For informative videos by The Health Master, click on the below YouTube icon:

YouTube Icon

For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:

YouTube Icon

For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:

YouTube Icon

For informative videos on consumer awareness, click on the below YouTube icon:

YouTube Icon
Telegram
WhatsApp
Facebook
LinkedIn
YouTube Icon
Google-news